Xu X - Search Results

1

Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma.

Shah PD, Huang AC, Xu X, Orlowski R, Amaravadi RK, Schuchter LM, Zhang P, Tchou J, Matlawski T, Cervini A, Shea J, Gilmore J, Lledo L, Dengel K, Marshall A, Wherry EJ, Linette GP, Brennan A, Gonzalez V, Kulikovskaya I, Lacey SF, Plesa G, June CH, Vonderheide RH, Mitchell TC. Shah PD, et al. Among authors: xu x. Cancer Res Commun. 2023 May 9;3(5):821-829. doi: 10.1158/2767-9764.CRC-22-0486. eCollection 2023 May. Cancer Res Commun. 2023. PMID: 37377890 Free PMC article. Clinical Trial.

2

Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.

Xu X, Chu AY, Pasha TL, Elder DE, Zhang PJ. Xu X, et al. Am J Surg Pathol. 2002 Jan;26(1):82-7. doi: 10.1097/00000478-200201000-00010. Am J Surg Pathol. 2002. PMID: 11756773

3

Expression of neurotrophin receptor Trk-C in nevi and melanomas.

Xu X, Tahan SR, Pasha TL, Zhang PJ. Xu X, et al. J Cutan Pathol. 2003 May;30(5):318-22. doi: 10.1034/j.1600-0560.2003.00068.x. J Cutan Pathol. 2003. PMID: 12753172

4

Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.

Kucher C, Zhang PJ, Pasha T, Elenitsas R, Wu H, Ming ME, Elder DE, Xu X. Kucher C, et al. Among authors: xu x. Am J Dermatopathol. 2004 Dec;26(6):452-7. doi: 10.1097/00000372-200412000-00002. Am J Dermatopathol. 2004. PMID: 15618925

5

Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.

Gombos Z, Xu X, Chu CS, Zhang PJ, Acs G. Gombos Z, et al. Among authors: xu x. Clin Cancer Res. 2005 Dec 1;11(23):8364-71. doi: 10.1158/1078-0432.CCR-05-1238. Clin Cancer Res. 2005. PMID: 16322297

6

Can Melan-A replace S-100 and HMB-45 in the evaluation of sentinel lymph nodes from patients with malignant melanoma?

Kucher C, Zhang PJ, Acs G, Roberts S, Xu X. Kucher C, et al. Among authors: xu x. Appl Immunohistochem Mol Morphol. 2006 Sep;14(3):324-7. doi: 10.1097/00129039-200609000-00011. Appl Immunohistochem Mol Morphol. 2006. PMID: 16932024

7

Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma.

Kumar SM, Yu H, Edwards R, Chen L, Kazianis S, Brafford P, Acs G, Herlyn M, Xu X. Kumar SM, et al. Among authors: xu x. Cancer Res. 2007 Apr 1;67(7):3177-84. doi: 10.1158/0008-5472.CAN-06-3312. Cancer Res. 2007. PMID: 17409425

8

Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma.

Xu X, Chen L, Guerry D, Dawson PR, Hwang WT, VanBelle P, Elder DE, Zhang PJ, Ming ME, Schuchter L, Gimotty PA. Xu X, et al. Clin Cancer Res. 2012 Jan 1;18(1):229-37. doi: 10.1158/1078-0432.CCR-11-0490. Epub 2011 Nov 17. Clin Cancer Res. 2012. PMID: 22096024 Free PMC article. Clinical Trial.

9

MITF accurately highlights epidermal melanocytes in atypical intraepidermal melanocytic proliferations.

Nybakken GE, Sargen M, Abraham R, Zhang PJ, Ming M, Xu X. Nybakken GE, et al. Among authors: xu x. Am J Dermatopathol. 2013 Feb;35(1):25-9. doi: 10.1097/DAD.0b013e31825666c3. Am J Dermatopathol. 2013. PMID: 22668579 Free PMC article.

10

Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3.

Abel EV, Basile KJ, Kugel CH 3rd, Witkiewicz AK, Le K, Amaravadi RK, Karakousis GC, Xu X, Xu W, Schuchter LM, Lee JB, Ertel A, Fortina P, Aplin AE. Abel EV, et al. Among authors: xu w, xu x. J Clin Invest. 2013 May;123(5):2155-68. doi: 10.1172/JCI65780. Epub 2013 Apr 1. J Clin Invest. 2013. PMID: 23543055 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57,929 results

Search Page

Filters